Investor Resources
Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The 2021 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Crinetics, or following a bona fide period of non-employment, as an inducement material to such individuals’ entering into employment with Crinetics, pursuant to Nasdaq Listing Rule 5635(c)(4).
The options have an exercise price of
About
Contacts:
Vice President of
cschultz@crinetics.com
(858) 450-6464
Media:
Head of Corporate Communications
nbadillo@crinetics.com
(858) 450-6464
Investors:
cdavis@lifesciadvisors.com
(212) 915-2577
Source: Crinetics Pharmaceuticals, Inc.